BLLN
BillionToOne, Inc.
Price Chart
Latest Quote
$101.89
+2.51 (+2.53%)
Current Price
| Previous Close | $99.38 |
| Open | $102.06 |
| Day High | $103.62 |
| Day Low | $100.01 |
| Volume | 66,715 |
Stock Information
| Shares Outstanding | 41.44M |
| Total Debt | $144.19M |
| Cash Equivalents | $537.45M |
| Revenue | $354.54M |
| Net Income | $24.88M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $4.69B |
| P/E Ratio | 188.69 |
| EPS (TTM) | $0.54 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.24B |
| Sales | $354.54M |
| Income | $24.88M |
| Book/sh | $11.00 |
| Cash/sh | $12.97 |
| Employees | 713 |
Financial Ratios
| Quick Ratio | 10.47 |
| Current Ratio | 10.92 |
| Debt/Eq | 28.52 |
Returns & Margins
| ROA | 4.46% |
| ROE | 8.73% |
| Gross Margin | 70.40% |
| Operating Margin | 16.45% |
| Profit Margin | 7.02% |
Ownership
| Insider Ownership | 46.83% |
| Institutional Ownership | 38.34% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 98.92 |
| P/S | 13.22 |
| P/B | 9.27 |
Analyst Data
| Recommendation | buy |
| Target Price | $117.71 |
Technical Indicators
| SMA20 | $96.63 |
| SMA50 | $88.93 |
| RSI | 52.67 |
| ATR | 7.6532 |
| Shares Float | 27.55M |
| Short Float | 6.74% |
| Short Ratio | 2.22 |
| Rel Volume | 0.09 |
Performance History
| Week | +2.25% |
| Month | +23.82% |
| Quarter | +37.69% |
| 6 Months | +10.80% |
| YTD | +14.11% |
| 10 Years | -6.47% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $101.89 | 66,715 |
| 2026-06-17 | $99.38 | 963,700 |
| 2026-06-16 | $100.70 | 724,400 |
| 2026-06-15 | $103.95 | 752,000 |
| 2026-06-12 | $101.12 | 552,800 |
| 2026-06-11 | $99.65 | 668,000 |
| 2026-06-10 | $99.26 | 1,040,600 |
| 2026-06-09 | $102.39 | 676,600 |
| 2026-06-08 | $94.43 | 773,400 |
| 2026-06-05 | $97.19 | 879,300 |
| 2026-06-04 | $104.59 | 1,162,600 |
| 2026-06-03 | $98.36 | 977,000 |
| 2026-06-02 | $94.25 | 931,400 |
| 2026-06-01 | $91.12 | 814,800 |
| 2026-05-29 | $98.99 | 405,800 |
| 2026-05-28 | $97.80 | 685,000 |
| 2026-05-27 | $91.02 | 800,300 |
| 2026-05-26 | $84.48 | 699,000 |
| 2026-05-22 | $85.92 | 374,600 |
| 2026-05-21 | $86.15 | 725,400 |
| 2026-05-20 | $83.38 | 676,300 |
| 2026-05-19 | $82.29 | 476,500 |
| 2026-05-18 | $86.12 | 600,500 |
About BillionToOne, Inc.
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
đ° Latest News
Are Medical Stocks Lagging Biodesix (BDSX) This Year?
Zacks âĸ 2026-06-15T13:40:04Z
Coastal Financial And 2 Additional Stocks Estimated To Be Priced Below Intrinsic Value
Simply Wall St. âĸ 2026-06-10T17:37:59Z
3 Stocks Conceivably Trading At Discounts Of Up To 49.6%
Simply Wall St. âĸ 2026-06-10T11:38:15Z
Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support
Investor's Business Daily âĸ 2026-06-06T12:00:14Z
Dow Jones Futures Rise, Techs Fall As AI Trade Cools; Jobs Report Looms
Investor's Business Daily âĸ 2026-06-05T21:15:02Z
3 Stocks That Could Be Trading At A Discount Of Up To 34.5%
Simply Wall St. âĸ 2026-06-05T17:38:14Z
June 2026's Top Stocks Estimated Below Intrinsic Value
Simply Wall St. âĸ 2026-06-05T11:38:16Z
Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?
Zacks âĸ 2026-05-29T13:40:03Z
3 Promising Growth Companies With Insider Ownership Up To 27%
Simply Wall St. âĸ 2026-05-26T11:36:57Z
Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect?
Zacks âĸ 2026-05-25T13:55:03Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $96,654,000 | - | - |
| Cost Of Revenue | $96,654,000 | - | - |
| Total Revenue | $305,112,000 | - | - |
| Operating Revenue | $305,112,000 | - | - |
| Expenses | |||
| Interest Expense | $95,000 | - | - |
| Total Expenses | $289,089,000 | - | - |
| Other Income Expense | $-15,919,000 | - | - |
| Other Non Operating Income Expenses | $-15,919,000 | - | - |
| Net Non Operating Interest Income Expense | $7,655,000 | - | - |
| Interest Expense Non Operating | $95,000 | - | - |
| Operating Expense | $192,435,000 | - | - |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $7,454,000 | - | - |
| Net Interest Income | $7,655,000 | - | - |
| Interest Income | $7,750,000 | - | - |
| Normalized Income | $7,454,000 | - | - |
| Net Income From Continuing And Discontinued Operation | $7,454,000 | - | - |
| Total Operating Income As Reported | $16,023,000 | - | - |
| Net Income Common Stockholders | $2,919,000 | - | - |
| Net Income | $7,454,000 | - | - |
| Net Income Including Noncontrolling Interests | $7,454,000 | - | - |
| Net Income Continuous Operations | $7,454,000 | - | - |
| Pretax Income | $7,759,000 | - | - |
| Special Income Charges | $0 | - | - |
| Interest Income Non Operating | $7,750,000 | - | - |
| Operating Income | $16,023,000 | - | - |
| Gross Profit | $208,458,000 | - | - |
| Per Share | |||
| Diluted EPS | $0.14 | $-1.05 | $-2.10 |
| Basic EPS | $0.18 | $-1.05 | $-2.10 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | - | - |
| Tax Rate For Calcs | $0 | - | - |
| Normalized EBITDA (Bullshit earnings) | $19,761,000 | - | - |
| Total Unusual Items | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $0 | - | - |
| Reconciled Depreciation | $11,907,000 | - | - |
| EBITDA (Bullshit earnings) | $19,761,000 | - | - |
| EBIT | $7,854,000 | - | - |
| Diluted Average Shares | $21,230,752 | $39,433,000 | $44,720,379 |
| Basic Average Shares | $15,875,091 | $39,433,000 | $39,433,000 |
| Diluted NI Availto Com Stockholders | $2,919,000 | - | - |
| Otherunder Preferred Stock Dividend | $4,535,000 | $0 | $0 |
| Tax Provision | $305,000 | - | - |
| Research And Development | $49,384,000 | - | - |
| Selling General And Administration | $143,051,000 | - | - |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $479,518,000 | $-251,883,000 | - |
| Total Assets | $632,654,000 | - | - |
| Total Non Current Assets | $72,096,000 | - | - |
| Other Non Current Assets | $4,993,000 | - | - |
| Goodwill And Other Intangible Assets | $587,000 | $227,000 | - |
| Other Intangible Assets | $587,000 | $227,000 | - |
| Current Assets | $560,558,000 | - | - |
| Other Current Assets | $5,421,000 | - | - |
| Inventory | $17,545,000 | - | - |
| Receivables | $41,617,000 | - | - |
| Accounts Receivable | $41,617,000 | - | - |
| Cash Cash Equivalents And Short Term Investments | $495,975,000 | - | - |
| Cash And Cash Equivalents | $495,975,000 | - | - |
| Debt | |||
| Total Debt | $108,895,000 | - | - |
| Long Term Debt And Capital Lease Obligation | $103,297,000 | - | - |
| Long Term Debt | $57,226,000 | - | - |
| Current Debt And Capital Lease Obligation | $5,598,000 | - | - |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $152,549,000 | - | - |
| Total Non Current Liabilities Net Minority Interest | $104,587,000 | - | - |
| Non Current Deferred Liabilities | $1,290,000 | $0 | - |
| Current Liabilities | $47,962,000 | - | - |
| Other Current Liabilities | $9,910,000 | $271,000 | - |
| Current Deferred Liabilities | $2,188,000 | - | - |
| Payables And Accrued Expenses | $17,715,000 | $10,671,000 | - |
| Payables | $7,372,000 | - | - |
| Total Tax Payable | $188,000 | - | - |
| Accounts Payable | $7,184,000 | - | - |
| Equity | |||
| Common Stock Equity | $480,105,000 | - | - |
| Total Equity Gross Minority Interest | $480,105,000 | - | - |
| Stockholders Equity | $480,105,000 | - | - |
| Gains Losses Not Affecting Retained Earnings | $-1,792,000 | $0 | - |
| Other Equity Adjustments | $-1,792,000 | - | - |
| Retained Earnings | $-274,747,000 | - | - |
| Preferred Securities Outside Stock Equity | $0 | - | - |
| Other | |||
| Ordinary Shares Number | $45,804,755 | $44,720,379 | $44,720,379 |
| Share Issued | $45,804,755 | $44,720,379 | $44,720,379 |
| Tangible Book Value | $479,518,000 | $-251,883,000 | - |
| Invested Capital | $537,331,000 | - | - |
| Working Capital | $512,596,000 | - | - |
| Capital Lease Obligations | $51,669,000 | - | - |
| Total Capitalization | $537,331,000 | - | - |
| Additional Paid In Capital | $756,644,000 | - | - |
| Capital Stock | $0 | - | - |
| Common Stock | $0 | - | - |
| Non Current Deferred Revenue | $1,290,000 | $0 | - |
| Long Term Capital Lease Obligation | $46,071,000 | - | - |
| Current Deferred Revenue | $2,188,000 | - | - |
| Current Capital Lease Obligation | $5,598,000 | - | - |
| Pensionand Other Post Retirement Benefit Plans Current | $12,551,000 | - | - |
| Current Accrued Expenses | $10,343,000 | $5,924,000 | - |
| Net PPE | $66,516,000 | $68,623,000 | - |
| Accumulated Depreciation | $-23,265,000 | $-17,149,000 | - |
| Gross PPE | $89,781,000 | - | - |
| Leases | $495,000 | - | - |
| Construction In Progress | $2,224,000 | - | - |
| Other Properties | $51,708,000 | - | - |
| Machinery Furniture Equipment | $35,354,000 | - | - |
| Properties | $0 | - | - |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $15,673,000 | - | - |
| Operating Activities | |||
| Operating Cash Flow | $24,595,000 | - | - |
| Cash Flow From Continuing Operating Activities | $24,595,000 | - | - |
| Operating Gains Losses | $7,419,000 | - | - |
| Investing Activities | |||
| Capital Expenditure | $-8,922,000 | - | - |
| Investing Cash Flow | $-8,922,000 | - | - |
| Cash Flow From Continuing Investing Activities | $-8,922,000 | - | - |
| Financing Activities | |||
| Repurchase Of Capital Stock | $0 | - | - |
| Issuance Of Capital Stock | $292,044,000 | - | - |
| Financing Cash Flow | $288,825,000 | - | - |
| Cash Flow From Continuing Financing Activities | $288,825,000 | - | - |
| Net Other Financing Charges | $-4,612,000 | - | - |
| Net Preferred Stock Issuance | $0 | - | - |
| Preferred Stock Issuance | $0 | - | - |
| Net Common Stock Issuance | $292,044,000 | - | - |
| Common Stock Issuance | $292,044,000 | $0 | $0 |
| Other | |||
| Repayment Of Debt | $-1,777,000 | - | - |
| Issuance Of Debt | $51,000 | - | - |
| Interest Paid Supplemental Data | $4,651,000 | - | - |
| Income Tax Paid Supplemental Data | $487,000 | - | - |
| End Cash Position | $495,975,000 | - | - |
| Beginning Cash Position | $191,477,000 | - | - |
| Changes In Cash | $304,498,000 | - | - |
| Proceeds From Stock Option Exercised | $3,119,000 | - | - |
| Common Stock Payments | $0 | - | - |
| Net Issuance Payments Of Debt | $-1,726,000 | - | - |
| Net Long Term Debt Issuance | $-1,726,000 | - | $12,961,000 |
| Long Term Debt Payments | $-1,777,000 | - | - |
| Long Term Debt Issuance | $51,000 | - | $15,051,000 |
| Net Investment Purchase And Sale | $0 | - | - |
| Sale Of Investment | $0 | - | - |
| Net Intangibles Purchase And Sale | $-41,000 | $0 | $0 |
| Purchase Of Intangibles | $-41,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-8,881,000 | - | - |
| Purchase Of PPE | $-8,881,000 | - | - |
| Change In Working Capital | $-22,053,000 | - | - |
| Change In Other Working Capital | $672,000 | - | - |
| Change In Other Current Liabilities | $-4,393,000 | - | - |
| Change In Other Current Assets | $-60,000 | - | - |
| Change In Payables And Accrued Expense | $9,641,000 | - | - |
| Change In Accrued Expense | $7,866,000 | - | - |
| Change In Payable | $1,775,000 | - | - |
| Change In Account Payable | $1,775,000 | - | - |
| Change In Prepaid Assets | $-2,193,000 | - | - |
| Change In Inventory | $-8,812,000 | - | - |
| Change In Receivables | $-16,908,000 | - | - |
| Changes In Account Receivables | $-16,908,000 | - | - |
| Other Non Cash Items | $3,953,000 | - | - |
| Stock Based Compensation | $15,915,000 | - | - |
| Depreciation Amortization Depletion | $11,907,000 | - | - |
| Depreciation And Amortization | $11,907,000 | - | - |
| Depreciation | $11,907,000 | - | - |
| Gain Loss On Investment Securities | $7,364,000 | - | - |
| Gain Loss On Sale Of PPE | $55,000 | - | - |
| Net Income From Continuing Operations | $7,454,000 | - | - |
Fetched: 2026-06-15